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Primary chordoma of the ethmoid sinus
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Abstract
Primary chordoma of the paranasal sinuses are extremely rare tumours, with only a small number of cases
veri￿ed and published in the literature. It appears that only ￿ve of these cases involved the ethmoid sinuses
either as a primary or by local invasion, and of these documented cases only one other has been found to solely
involve the ethmoid sinus. We present a case of primary ethmoid sinus chordoma treated by wide local surgical
excision and present a review of the literature with regard to prevalence and treatment rationale.
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Introduction
Chordomata are uncommon dysontogenic malignant neo-
plasms that are thought to arise either from residual
remnants of the embryonic notochord or from ectopic
chordal nodules.
1,2 There are three main sites of occur-
rence: spheno-occipital, vertebral and sacro-coccygeal, of
which approximately one third arise in the spheno-
occipital,
3 and it is amongst this group that the otolar-
yngologist may encounter this disease. Among the
commoner presentations include the presence of a
nasopharyngeal mass from direct spread from a lesion of
the clivus. Presentation as a solitary lesion affecting one or
more paranasal sinuses is extremely rare and is usually
discovered by the pathologist. Table I shows the ￿ve cases
of chordoma involving the ethmoid sinus that have been
reported,
4–7 with only of those con￿rmed as solely
involving the ethmoid sinus.
4 An additional case is
presented and the radiographical ￿ndings and treatment
rationale discussed.
Case report
A 42-year-old woman presented initially to the ophthalmic
surgeons with a one month history of discomfort and
swelling at the medial canthus of the left eye; she had no
overt nasal symptoms. Examination con￿rmed a soft
swelling at the medial canthus with no other ophthalmic
signs. A computed tomography (CT) scan revealed
opaci￿cation of the left frontal and ethmoid sinuses with
a suggestion of some destruction of the medial orbital wall
(Figure 1). Coronal MRI with gadolinium demonstrated
enhancement of the tumour (Figure 2). She was referred
for an ENT opinion and underwent an endoscopic
examination and biopsy. This revealed a polypoidal lesion
in the left fronto-nasal recess, which proved histologically
to be a chordoma (Figure 3).
The patient underwent a lateral rhinotomy approach
that showed the tumour ￿lling the anterior ethmoid
sinuses, extending into the middle turbinate and abutting
the adjacent orbital periosteum. The ethmoid sinuses were
cleared and the middle turbinate was dissected off the skull
base, the frontal sinus was opened and the mucosa
stripped, and the affected area of orbital periosteum was
excised.
The patient made an uneventful post-operative recovery
and was discharged two days later. She has had a 12 month
follow-up by endoscopic examination and magnetic reso-
nance imaging (MRI) that has failed to show evidence of
recurrence. However, the patient has been counselled that
if recurrence occurred periorbitally, an orbital clearance
might be required.
Discussion
A chordoma is a rare, malignant, slow-growing tumour
that can present in the nasal cavity by anterior extension
from the clivus involving the ethmoid sinuses. Isolated
chordomas of the paranasal sinuses are extremely rare.
Only ￿ve other cases in the English literature have been




9 independently described this
lesion and at that time felt it most likely represented a
tumour of cartilaginous origin. This view was held until
Muller
10 recognized it as notochordal tissue and coined the
term ‘ecchordosis physaliphora’, because of the character-
istic physaliphorous cells.
The presenting symptoms of chordoma depends on the
site of involvement; clival lesions usually present late, after
intracranial extension, and therefore, cranial nerve
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7 1 Antro-ethmoid and orbit
Present study 1 Ethmoid
627involvement and signs of increased intracranial pressure
predominate. If the tumour spreads anteriorly, nasal
obstruction, mucopurulent discharge and epistaxis may
occur.
11 Computed tomography (CT) scanning is optimally
employed to demonstrate bony destruction although the
lesion is best shown by MRI, revealing a high T2 signal and
enhancement on T1-post-gadolinium.
Macroscopically, the tumour is lobulated and gelatinous
in nature, often with a pseudocapsule and areas of
dystrophic calci￿cation. Microscopically, the tumour is
variable, and is usually composed of certain proportions of
three cell types: stellate cells, intermediate cells, and
physaliphorous cells.
12 There is abundant intercellular
mucoid matrix, and stains for mucus and glycogen are
positive. Immunochemistry for cytokeratins and S100 are
positive. All the above make the diagnosis dif￿cult and
confusion can arise with the most common misdiagnoses
being mixed salivary gland tumour, chondroma, chondro-
sarcoma, mucocele etc.
Treatment of the lesion depends on the site and
extension of the disease. Clival or sphenoid lesions are
often too advanced for complete surgical resection.
However, debulking combined with post-operative radio-
therapy is often employed, despite the tumour being
relatively radioresistant. The more anterior, ectopic foci
occurring in the frontal, ethmoid and maxillary sinuses are
far more amenable to full surgical excision and the
prognosis therefore appears more favourable. A relatively
large series of cases (six) studied by Berdal and Myhre
4
showed excellent survival rates with a number of probable
cures, and one patient alive with recurrence 25 years
following initial diagnosis.
Fig. 1
Coronal CT scan image of the nose and paranasal sinuses
showing opacification of the left frontal and ethmoid sinuses
with a suggestion of some bone destruction of the medial
orbital wall.
Fig. 2
Coronal MRI scan T1-gadolinium-enhanced image to show
the high uptake of the tumour.
Fig. 3
Pathology. The specimens showed widespread infiltration of a
neoplasm composed of small groups of epithelioid cells with
nuclear hyperchromasia and moderate nuclear pleomorphism.
Many of the nuclei contained intranuclear cytoplasmic
inclusions, and the cytoplasm was abundant and eosinophilic.
Immunostaining showed positivity for vimentin, EMA, S100
and, was weakly positive for LP34. This pattern of immuno-
profile was in keeping with a chordoma. (3 400)
628 s. loughran, l. badia, v. lundWe present an additional case of primary chordoma of
the ethmoid sinus, and although the literature is somewhat
sparse, we conclude that initial treatment for chordomata
presenting in the paranasal sinuses is primary surgical
excision; with the understanding that the slow growth rate
of the tumour may mean late recurrences, that in
themselves may require revision surgery. Radiotherapy
has a place to play in such recurrences or in cases where
excision is felt to be incomplete.
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